Acknowledging the Intersection of Gender Inequity and Racism: Identifying a Path Forward in Pharmacy

April 15, 2022

In this podcast episode, Dr. Jacinda Abdul-Mutakabbir, Dr. Vibhuti Arya, and Dr. Lakesha Butler discuss their commentary, “Acknowledging the Intersection of Gender Inequity and Racism: Identifying a Path Forward in Pharmacy,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

View the Article


Jacinda Abdul-MutakabbirDr. Jacinda Abdul-Mutakabbir is currently an Assistant Professor at Loma Linda School of Pharmacy in Loma Linda, CA. She completed her Doctorate in Pharmacy at the University of Saint Joseph School of Pharmacy, an accelerated three-year pharmacy program, located in Hartford, CT. Following pharmacy school, she completed her pharmacy residency at the Howard University Hospital in Washington, DC. She also completed an Infectious Disease Pharmacokinetics/ Pharmacodynamics (PK/PD) Research Fellowship under the tutelage of Dr. Michael J. Rybak PharmD, MPH, PhD, and went on to earn a Masters of Public Health at Wayne State University in Detroit, MI. As an emerging practitioner, her primary research interests include translating her in vitro research, focusing on multidrug-resistant bacteria, to improve patient treatment strategies in vivo. Her dedication to improving public health has been recognized by the United States Public Health Services, as she was the 2017 recipient of the USPHS Outstanding Service Award. Additionally, her research has led her to be recognized by the European Congress of Clinical Microbiology and Infectious Diseases one of their 30 under 30 outstanding young scientists, for their ECCMID 2021 31st annual meeting. Dr. Abdul-Mutakabbir continues to be an active member of several professional organization including the American Academy of HIV Medicine (AAHIVM), Infectious Diseases Society of America (IDSA), American Society of Microbiology (ASM), and the Society of Infectious Disease Pharmacists (SIDP).

Vibhuti AryaVibhuti Arya, PharmD, MPH, FAPhA is a public health pharmacist who brings together her experiences in social justice, education, theatre, and mindfulness to create brave spaces for people and systems to intentionally work towards dismantling structural racism and engage in anti-oppression work. In her role at the NYC Health Department, Dr. Arya integrates pharmacists into public health initiatives and advises on legislation, particularly among high-risk, medically underserved areas in NYC. Dr. Arya also serves on the Health Department’s Institutional Review Board, the APhA Taskforce on Systemic Racism, received the Sustained Contributor Award from the American Public Health Association Pharmacy Section, and led a team to win the MIT Hacking Racism Challenge in Social Justice & Policy.

Dr. Arya is a Global Lead for Gender Equity and Diversity Workforce Development for the International Pharmaceutical Federation (FIP) and delivered a TEDx talk on structural racism. She earned her PharmD from St. John’s University, completed the Pharmaceutical Care Leadership Residency at the University of Minnesota, and earned her MPH from the Johns Hopkins Bloomberg School of Public Health.

Lakesha ButlerDr. Lakesha Butler is a Clinical Professor of Pharmacy Practice and Director of Diversity, Equity and Inclusion at Southern Illinois University Edwardsville (SIUE) School of Pharmacy. She is also the past president of the National Pharmaceutical Association. Dr. Butler received her doctorate of pharmacy from Mercer University and completed a PGY-1 residency at the University of Illinois at Chicago. She is a certified diversity facilitrainer (CDFT).



iTunes      Google      Stitcher      Spotify      TuneIn      iHeart Radio

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.